KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹26 Cr |
Mar2024 | ₹0.99 Cr |
Mar2023 | ₹-20 Cr |
Mar2022 | ₹123 Cr |
Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹26 Cr | 2,515.57 | |
Mar2024 | ₹0.99 Cr | Positive | |
Mar2023 | ₹-20 Cr | Negative | |
Mar2022 | ₹123 Cr | Positive | |
Mar2021 | ₹-35 Cr | - |
Compare Cash Flow from Financing Activities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹858.3 Cr | -2.5% | 13% | -47.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,497.0 Cr | 1.1% | -1.9% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,787.0 Cr | 1.1% | -0.6% | 10.4% | Stock Analytics | |
CIPLA | ₹125,870.0 Cr | -0.4% | -0.4% | -6.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,591.0 Cr | -1.7% | -2.5% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,380.0 Cr | 0.5% | 4.1% | -2.7% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -2.5% |
13% |
-47.7% |
SENSEX | 1.6% |
2.3% |
1.1% |
You may also like the below Video Courses